These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 11774242)

  • 1. Cell type- and promoter-dependent modulation of the Wnt signaling pathway by sodium butyrate.
    Bordonaro M; Lazarova DL; Augenlicht LH; Sartorelli AC
    Int J Cancer; 2002 Jan; 97(1):42-51. PubMed ID: 11774242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Butyrate-induced apoptotic cascade in colonic carcinoma cells: modulation of the beta-catenin-Tcf pathway and concordance with effects of sulindac and trichostatin A but not curcumin.
    Bordonaro M; Mariadason JM; Aslam F; Heerdt BG; Augenlicht LH
    Cell Growth Differ; 1999 Oct; 10(10):713-20. PubMed ID: 10547075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Replicating parvoviruses that target colon cancer cells.
    Malerba M; Daeffler L; Rommelaere J; Iggo RD
    J Virol; 2003 Jun; 77(12):6683-91. PubMed ID: 12767988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of AXIN2 expression by beta-catenin-T cell factor. A feedback repressor pathway regulating Wnt signaling.
    Leung JY; Kolligs FT; Wu R; Zhai Y; Kuick R; Hanash S; Cho KR; Fearon ER
    J Biol Chem; 2002 Jun; 277(24):21657-65. PubMed ID: 11940574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta-catenin/Tcf-1-mediated transactivation of cyclin D1 promoter is negatively regulated by thyroid hormone.
    Natsume H; Sasaki S; Kitagawa M; Kashiwabara Y; Matsushita A; Nakano K; Nishiyama K; Nagayama K; Misawa H; Masuda H; Nakamura H
    Biochem Biophys Res Commun; 2003 Sep; 309(2):408-13. PubMed ID: 12951064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Negative regulation of the Wnt-beta-catenin pathway by the transcriptional repressor HBP1.
    Sampson EM; Haque ZK; Ku MC; Tevosian SG; Albanese C; Pestell RG; Paulson KE; Yee AS
    EMBO J; 2001 Aug; 20(16):4500-11. PubMed ID: 11500377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wnt-1 but not epidermal growth factor induces beta-catenin/T-cell factor-dependent transcription in esophageal cancer cells.
    Mizushima T; Nakagawa H; Kamberov YG; Wilder EL; Klein PS; Rustgi AK
    Cancer Res; 2002 Jan; 62(1):277-82. PubMed ID: 11782388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells.
    Tetsu O; McCormick F
    Nature; 1999 Apr; 398(6726):422-6. PubMed ID: 10201372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wnt breakers in colon cancer.
    Clevers H
    Cancer Cell; 2004 Jan; 5(1):5-6. PubMed ID: 14749120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. gamma-catenin is regulated by the APC tumor suppressor and its oncogenic activity is distinct from that of beta-catenin.
    Kolligs FT; Kolligs B; Hajra KM; Hu G; Tani M; Cho KR; Fearon ER
    Genes Dev; 2000 Jun; 14(11):1319-31. PubMed ID: 10837025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of cyclooxygenase-2 expression by the Wnt and ras pathways.
    Araki Y; Okamura S; Hussain SP; Nagashima M; He P; Shiseki M; Miura K; Harris CC
    Cancer Res; 2003 Feb; 63(3):728-34. PubMed ID: 12566320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-talk between Rac1 GTPase and dysregulated Wnt signaling pathway leads to cellular redistribution of beta-catenin and TCF/LEF-mediated transcriptional activation.
    Esufali S; Bapat B
    Oncogene; 2004 Oct; 23(50):8260-71. PubMed ID: 15377999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic cooperation between the beta-catenin signaling pathway and steroidogenic factor 1 in the activation of the Mullerian inhibiting substance type II receptor.
    Hossain A; Saunders GF
    J Biol Chem; 2003 Jul; 278(29):26511-6. PubMed ID: 12724325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The human T-cell factor-4 gene splicing isoforms, Wnt signal pathway, and apoptosis in renal cell carcinoma.
    Shiina H; Igawa M; Breault J; Ribeiro-Filho L; Pookot D; Urakami S; Terashima M; Deguchi M; Yamanaka M; Shirai M; Kaneuchi M; Kane CJ; Dahiya R
    Clin Cancer Res; 2003 Jun; 9(6):2121-32. PubMed ID: 12796377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TCF: Lady Justice casting the final verdict on the outcome of Wnt signalling.
    Brantjes H; Barker N; van Es J; Clevers H
    Biol Chem; 2002 Feb; 383(2):255-61. PubMed ID: 11934263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lycopene synergistically enhances quinacrine action to inhibit Wnt-TCF signaling in breast cancer cells through APC.
    Preet R; Mohapatra P; Das D; Satapathy SR; Choudhuri T; Wyatt MD; Kundu CN
    Carcinogenesis; 2013 Feb; 34(2):277-86. PubMed ID: 23129580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ITF-2, a downstream target of the Wnt/TCF pathway, is activated in human cancers with beta-catenin defects and promotes neoplastic transformation.
    Kolligs FT; Nieman MT; Winer I; Hu G; Van Mater D; Feng Y; Smith IM; Wu R; Zhai Y; Cho KR; Fearon ER
    Cancer Cell; 2002 Mar; 1(2):145-55. PubMed ID: 12086873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p73beta, a variant of p73, enhances Wnt/beta-catenin signaling in Saos-2 cells.
    Ueda Y; Hijikata M; Takagi S; Takada R; Takada S; Chiba T; Shimotohno K
    Biochem Biophys Res Commun; 2001 May; 283(2):327-33. PubMed ID: 11327702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1.
    Satoh S; Daigo Y; Furukawa Y; Kato T; Miwa N; Nishiwaki T; Kawasoe T; Ishiguro H; Fujita M; Tokino T; Sasaki Y; Imaoka S; Murata M; Shimano T; Yamaoka Y; Nakamura Y
    Nat Genet; 2000 Mar; 24(3):245-50. PubMed ID: 10700176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Smads with lymphoid enhancer binding factor 1/T cell-specific factor mediates cooperative signaling by the transforming growth factor-beta and wnt pathways.
    Labbé E; Letamendia A; Attisano L
    Proc Natl Acad Sci U S A; 2000 Jul; 97(15):8358-63. PubMed ID: 10890911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.